EYPT EyePoint, Inc. - Common Stock
Tentang EyePoint, Inc. - Common Stock Tinjauan perusahaan dari Wikipedia
EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems (MEMS) and nanotechnology to drug delivery.
Baca selengkapnya
EyePoint Pharmaceuticals Inc. (formerly pSivida Corporation) is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems (MEMS) and nanotechnology to drug delivery.
pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency (DERA, now QinetiQ). QinetiQ continues to be a strategic partner.
In June 2004, pSivida acquired full ownership of pSiMedica. In April 2018, pSivida purchased eye products firm Icon Bioscience. Afterwards, it rebranded to its current name of EyepOint Pharmaceuticals, Inc.
Sumber: Wikipedia (English), CC BY-SA 4.0 · Lihat di Wikipedia ↗
EYPT Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
EYPT Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
EYPT Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
- Beli Kuat 7 35,0%
- Beli 12 60,0%
- Tahan 1 5,0%
- Jual 0 0,0%
- Jual Kuat 0 0,0%
Target Harga 12 Bulan
13 analis · 2026-08-19Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
| Periode | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|
| 30 Juni 2026 | $-1.09 | $-0.97 | -0.12% |
| 31 Maret 2026 | $-0.99 | $-0.82 | -0.17% |
| 31 Des. 2025 | $-0.81 | $-0.76 | -0.05% |
| 30 Sep. 2025 | $-0.85 | $-0.80 | -0.05% |
| 30 Juni 2025 | $-0.85 | $-0.81 | -0.04% |
| 31 Maret 2025 | $-0.65 | $-0.67 | 0.02% |
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| EYPT | $1.51B | -5.8 | -27.5% | -739.4% | -84.0% | — |
| XERS | $1.30B | — | 43.7% | 0.19% | -19.7% | — |
| PAHC | — | 21.5 | 27.4% | 3.7% | 17.8% | 30.9% |
| SPTX | — | — | — | — | — | — |
| ANRO | $568M | -8.1 | — | — | -46.1% | — |
| OMER | $1.23B | -343.6 | — | — | 1.9% | — |
| LXRX | $421M | -8.2 | 60.2% | -101.1% | -39.7% | — |
| PCRX | $1.06B | 161.8 | 3.6% | 0.97% | 0.97% | — |
| LLY | — | 46.8 | 44.7% | 31.7% | 101.2% | — |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi 16
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $31M | $43M | $46M | $41M | $37M | $34M | $20M | $5M | $8M | $2M | $27M | |
| R&D Expense | $221M | $133M | $65M | $50M | $28M | $17M | $15M | $19M | $15M | $14M | $12M | |
| SG&A Expense | $52M | $52M | $40M | $35M | $26M | $21M | $18M | $15M | $11M | $9M | $8M | |
| Operating Expenses | $275M | $189M | $121M | $141M | $92M | $72M | $68M | $44M | $26M | $23M | $20M | |
| Operating Income | $-243M | $-146M | $-75M | $-100M | $-55M | $-37M | $-48M | $-39M | $-19M | $-22M | $6M | |
| Interest Expense | · | · | $1M | $3M | $5M | $7M | $6M | $2M | $0 | $0 | · | |
| Interest Income | · | · | · | · | · | · | · | · | · | · | $19.0K | |
| Other Non-op | $12M | $15M | $7M | $2M | $292.0K | $58.0K | $1M | $420.0K | $91.0K | $72.0K | $22.0K | |
| Pretax Income | $-232M | $-131M | $-71M | $-102M | $-58M | $-45M | $-57M | · | $-18M | $-22M | $6M | |
| Income Tax | $279.0K | $90.0K | $83.0K | · | $0 | $0 | $0 | · | $0 | $-155.0K | $96.0K | |
| Net Income | $-232M | $-131M | $-71M | $-102M | $-58M | $-45M | $-57M | $-86M | $-18M | $-22M | $6M | |
| EPS (Basic) | $-3.17 | $-2.32 | $-1.82 | $-2.74 | $-2.03 | · | · | · | $-0.52 | $-0.68 | $0.22 | |
| EPS (Diluted) | $-3.17 | $-2.32 | $-1.82 | $-2.74 | $-2.03 | · | · | · | $-0.52 | $-0.68 | $0.21 | |
| Shares (Basic) | 73,251 | 56,298 | 38,904 | 37,317,000 | 28,758,000 | · | · | · | 35,343,765 | 31,623,473 | 29,378,250 | |
| Shares (Diluted) | 73,251 | 56,298 | 38,904 | 37,317,000 | 28,758,000 | · | · | · | 35,343,765 | 31,623,473 | 30,584,140 | |
| EBITDA | $-241M | $-146M | $-75M | $-100M | $-55M | · | $-48M | · | · | $-22M | $6M |
Neraca 27
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $102M | $100M | $281M | $96M | $179M | $45M | $22M | $45M | $17M | $15M | $19M | |
| Short-term Investments | $204M | $271M | $50M | $49M | $33M | $0 | $0 | $0 | $0 | $14M | $9M | |
| Inventory | $2M | $2M | $4M | $3M | $4M | $5M | $2M | $279.0K | · | · | · | |
| Prepaid Expense | $20M | $9M | $9M | $10M | $4M | $3M | $6M | $1M | $591.0K | $483.0K | $681.0K | |
| Other Current Assets | $2M | $1M | $1M | $782.0K | $517.0K | · | · | · | · | · | · | |
| Current Assets | $329M | $383M | $345M | $173M | $238M | $63M | $42M | $48M | $18M | $30M | $30M | |
| PP&E (Net) | $9M | $8M | $5M | $1M | $476.0K | $630.0K | $357.0K | $288.0K | $313.0K | $290.0K | $338.0K | |
| PP&E (Gross) | $15M | $12M | $8M | $3M | $2M | $2M | $1M | $983.0K | $799.0K | $2M | $2M | |
| Accum. Depreciation | $6M | $4M | $3M | $2M | $1M | $1M | $839.0K | $695.0K | $486.0K | $2M | $2M | |
| Intangibles | · | · | · | $0 | $23M | $25M | $28M | $30M | $364.0K | $1M | $2M | |
| Other Non-current Assets | $6M | $6M | $0 | · | · | · | · | · | · | · | · | |
| Total Assets | $364M | $418M | $355M | $180M | $263M | $92M | $73M | $78M | $19M | $32M | $32M | |
| Accounts Payable | $10M | $12M | $7M | $6M | $7M | $5M | $4M | $3M | $1M | $1M | $744.0K | |
| Accrued Liabilities | $24M | $18M | $18M | $16M | $14M | $8M | $7M | $4M | $4M | $4M | $3M | |
| Short-term Debt | · | · | $0 | $10M | $0 | · | · | · | · | · | · | |
| Current Liabilities | $37M | $49M | $63M | $35M | $24M | $15M | $12M | $21M | $5M | $5M | $3M | |
| Capital Leases | $21M | $22M | $5M | $6M | $2M | $2M | $3M | $0 | · | · | · | |
| Other Non-current Liabilities | $87.0K | $205.0K | $0 | $600.0K | $2M | $2M | $3M | $1M | $51.0K | · | · | |
| Total Liabilities | $58M | $82M | $89M | $84M | $79M | $73M | $65M | $41M | $5M | $11M | $9M | |
| Long-term Debt | · | · | · | $30M | · | · | · | · | · | · | · | |
| Total Debt | · | · | $0 | $40M | $37M | · | $47M | · | · | · | · | |
| Common Stock | $83.0K | $68.0K | $49.0K | $34.0K | $34.0K | $18.0K | $11.0K | $95.0K | $39.0K | $34.0K | $29.0K | |
| Retained Earnings | $-1.10B | $-873M | $-742M | $-671M | $-569M | $-511M | $-465M | $-408M | $-311M | $-292M | $-271M | |
| AOCI | $961.0K | $1M | $864.0K | $786.0K | $841.0K | $841.0K | $840.0K | $839.0K | $833.0K | $852.0K | $945.0K | |
| Stockholders' Equity | $306M | $337M | $266M | $96M | $184M | $19M | $8M | $38M | $13M | $21M | $23M | |
| Liabilities + Equity | $364M | $418M | $355M | $180M | $263M | $92M | $73M | $78M | $19M | $32M | $32M | |
| Shares Outstanding | 82,826,416 | 68,266,005 | 49,043,074 | 34,082,934 | 33,905,826 | 18,139,981 | 10,941,659 | 95,372,236 | 39,356,999 | 34,172,919 | 29,412,365 |
Arus Kas 18
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $464.0K | · | · | · | · | · | · | · | · | |
| Stock-based Comp | $28M | $37M | $12M | $14M | $7M | $6M | $5M | · | $2M | $2M | $2M | |
| Deferred Tax | $279.0K | $90.0K | $83.0K | · | · | · | · | · | · | · | · | |
| Amort. of Intangibles | · | · | $0 | $2M | $2M | $2M | $2M | $981.0K | $724.0K | $756.0K | $770.0K | |
| Restructuring | · | · | · | · | · | $590.0K | · | · | $472.0K | · | · | |
| Other Non-cash | $-39M | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-240M | $-126M | $2M | $-65M | $-50M | $-14M | $-57M | · | $-20M | $-16M | $10M | |
| CapEx | $3M | $4M | $3M | $2M | $156.0K | $362.0K | $213.0K | · | $147.0K | $113.0K | $161.0K | |
| Investing Cash Flow | $69M | $-219M | $-3M | $-17M | $-33M | $-362.0K | $-213.0K | · | $14M | $-4M | · | |
| Debt Issued | · | · | $0 | $30M | $0 | · | $50M | · | $0 | $0 | · | |
| Net Debt Issued | · | $0 | $-30M | $-8M | $0 | · | $30M | · | · | · | · | |
| Stock Issued | $173M | $163M | $226M | $0 | · | $50M | $23M | · | $8M | $16M | $0 | |
| Net Stock Activity | $173M | $163M | $226M | · | · | · | $23M | · | · | $16M | · | |
| Financing Cash Flow | $174M | $164M | $187M | $-690.0K | $217M | $37M | $34M | · | $9M | $17M | · | |
| Net Change in Cash | $2M | $-182M | $186M | $-83M | $134M | $23M | $-23M | · | $2M | $-4M | $4M | |
| Taxes Paid | $200.0K | $100.0K | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-243M | $-130M | $-2M | $-67M | $-50M | · | $-57M | · | · | $-16M | $10M | |
| Levered FCF | · | · | $-3M | $-70M | $-56M | · | $-63M | · | · | · | · |
Profitabilitas 7
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -776.0% | -337.1% | -163.1% | -240.6% | -149.6% | · | -235.0% | · | · | -1344.1% | 24.2% | |
| Net Margin | -739.4% | -302.4% | -153.8% | -247.0% | -158.1% | · | -278.9% | · | · | -1330.1% | 23.9% | |
| Pretax Margin | -738.5% | -302.2% | -153.7% | -247.0% | -158.1% | · | -278.9% | · | · | -1339.6% | 24.2% | |
| EBITDA Margin | -768.6% | -337.1% | -163.1% | -240.6% | -149.6% | · | -235.0% | · | · | -1344.1% | 24.2% | |
| ROA | -59.3% | -33.8% | -26.4% | -46.1% | -32.9% | · | -75.1% | · | · | -67.3% | 23.1% | |
| ROE | -84.0% | -47.1% | -43.6% | -87.9% | -42.2% | · | -468.1% | · | · | -90.8% | 24.8% | |
| ROIC | -79.6% | -43.4% | -28.2% | -73.2% | -25.0% | · | -86.2% | · | · | -103.5% | 27.1% |
Likuiditas & Solvabilitas 5
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.9 | 7.8 | 5.5 | 5.0 | 10.0 | · | 3.6 | · | · | 5.9 | 8.9 | |
| Quick Ratio | 8.3 | 7.6 | 5.2 | 4.2 | 8.9 | · | 1.9 | · | · | 5.7 | 8.5 | |
| Debt / Equity | · | · | 0.0 | 0.4 | 0.2 | · | 5.7 | · | · | · | · | |
| LT Debt / Equity | · | · | · | 0.3 | 0.2 | · | 5.7 | · | · | · | · | |
| Interest Coverage | · | · | -60.2 | -31.2 | -10.1 | · | -7.7 | · | · | · | · |
Efisiensi 1
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | · | 0.3 | · | · | 0.1 | 1.0 |
Tingkat Pertumbuhan 3
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -27.5% | -6.0% | 11.1% | 12.1% | 7.3% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -8.8% | 5.4% | 10.2% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -1.8% | · | · | · | · | · | · | · | · | · | · |
Valuasi (TTM) 14
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $31M | $43M | $46M | $41M | $37M | $34M | $20M | · | $8M | $2M | $27M | |
| Net Income TTM | $-232M | $-131M | $-71M | $-102M | $-58M | $-45M | $-57M | · | $-18M | $-22M | $6M | |
| Market Cap | $1.51B | $509M | $1.13B | $119M | $415M | · | $1.70B | · | · | $967M | $1.11B | |
| Enterprise Value | · | · | $802M | $15M | $240M | · | $1.72B | · | · | · | · | |
| P/E | -5.8 | -3.2 | -12.7 | -1.3 | -6.0 | -9.8 | -23.1 | · | -32.9 | -41.6 | 179.5 | |
| P/S | 48.2 | 11.8 | 24.6 | 2.9 | 11.2 | · | 83.3 | · | · | 597.0 | 41.7 | |
| P/B | 4.9 | 1.5 | 4.3 | 1.2 | 2.3 | · | 203.6 | · | · | 46.3 | 47.5 | |
| P / Tangible Book | 4.9 | 1.5 | 4.3 | 1.2 | 2.6 | · | · | · | · | · | · | |
| P / Cash Flow | -6.3 | -4.0 | 604.5 | -1.8 | -8.3 | · | -29.9 | · | · | -59.3 | 107.7 | |
| P / FCF | -6.2 | -3.9 | -704.8 | -1.8 | -8.3 | · | -29.8 | · | · | -58.9 | 109.4 | |
| EV / EBITDA | · | · | -10.7 | -0.1 | -4.3 | · | -36.0 | · | · | · | · | |
| EV / FCF | · | · | -499.0 | -0.2 | -4.8 | · | -30.2 | · | · | · | · | |
| EV / Revenue | · | · | 17.4 | 0.4 | 6.5 | · | 84.5 | · | · | · | · | |
| Earnings Yield | -17.3% | -31.1% | -7.9% | -78.3% | -16.6% | -10.2% | -4.3% | · | -3.0% | -2.4% | 0.56% |
Laporan Laba Rugi 16
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $507.0K | $696.0K | $619.0K | $966.0K | $5M | $24M | $12M | $11M | $9M | $12M | $14M | $15M | $9M | $8M | $11M | $10M | |
| Cost of Revenue | · | · | · | · | · | · | · | $736.0K | $1M | $759.0K | · | $1M | $2M | $640.0K | · | · | |
| R&D Expense | $84M | $72M | $59M | $48M | $55M | $59M | $43M | $30M | $30M | $30M | $18M | $17M | $16M | $14M | $16M | $11M | |
| SG&A Expense | $14M | $15M | $11M | $14M | $12M | $14M | $13M | $13M | $13M | $14M | $11M | $11M | $9M | $9M | $8M | $9M | |
| Operating Expenses | $98M | $88M | $71M | $63M | $68M | $73M | $57M | $43M | $44M | $45M | $30M | $30M | $32M | $29M | $54M | $28M | |
| Operating Income | $-97M | $-87M | $-70M | $-62M | $-62M | $-49M | $-45M | $-33M | $-35M | $-33M | $-16M | $-14M | $-23M | $-22M | $-44M | $-18M | |
| Interest Expense | · | · | · | · | · | · | · | · | $0 | $0 | · | $0 | $435.0K | $812.0K | $781.0K | $662.0K | |
| Other Non-op | $3M | $2M | $3M | $2M | $3M | $4M | $4M | $3M | $4M | $4M | $2M | $2M | $2M | $1M | $1M | $640.0K | |
| Pretax Income | $-94M | · | $-67M | $-60M | $-59M | · | $-41M | $-29M | $-31M | · | · | · | · | · | · | · | |
| Income Tax | $0 | $-50.0K | $186.0K | $0 | $93.0K | $0 | $90.0K | $0 | $0 | · | · | · | · | · | · | · | |
| Net Income | $-94M | $-85M | $-68M | $-60M | $-59M | $-45M | $-41M | $-29M | $-31M | $-29M | $-14M | $-13M | $-23M | $-21M | $-43M | $-18M | |
| EPS (Basic) | $-1.09 | $-0.99 | $-0.82 | $-0.85 | $-0.85 | $-0.65 | $-0.65 | $-0.54 | $-0.58 | $-0.55 | $-0.32 | $-0.33 | $-0.61 | $-0.56 | $-1.17 | $-0.49 | |
| EPS (Diluted) | $-1.09 | $-0.99 | $-0.82 | $-0.85 | $-0.85 | $-0.65 | $-0.65 | $-0.54 | $-0.58 | $-0.55 | $-0.32 | $-0.33 | $-0.61 | $-0.56 | $-1.17 | $-0.49 | |
| Shares (Basic) | 86,543 | 85,999 | -69,833,843 | 70,168 | 69,926 | 69,767 | -52,964,357 | 54,449 | 53,206 | 52,913,000 | -75,915,582 | 38,341,000 | 37,576,000 | 37,486 | -74,596,000 | 37,338,000 | |
| Shares (Diluted) | 86,543 | 85,999 | -69,833,843 | 70,168 | 69,926 | 69,767 | -52,964,357 | 54,449 | 53,206 | 52,913,000 | -75,915,582 | 38,341,000 | 37,576,000 | 37,486 | -74,596,000 | 37,338,000 | |
| EBITDA | $-97M | $-87M | · | $-62M | $-62M | $-49M | · | $-33M | $-35M | $-33M | · | $-14M | $-23M | $-22M | · | $-18M |
Neraca 27
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $110M | $78M | $102M | $75M | $71M | $85M | $100M | $80M | $91M | $271M | $281M | $133M | $140M | $106M | $96M | $75M | |
| Short-term Investments | $70M | $145M | $204M | $129M | $185M | $233M | $271M | $174M | $189M | $28M | $50M | $3M | $3M | $17M | $49M | $82M | |
| Inventory | $2M | $1M | $2M | $2M | $3M | $2M | $2M | $3M | $4M | $4M | $4M | $5M | $4M | $4M | $3M | $4M | |
| Prepaid Expense | $6M | $25M | $20M | $9M | $6M | $6M | $9M | $12M | $10M | $11M | $9M | $9M | $9M | $9M | $10M | $10M | |
| Other Current Assets | $987.0K | $1M | $2M | $899.0K | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $549.0K | $0 | $0 | $782.0K | · | |
| Current Assets | $189M | $250M | $329M | $216M | $265M | $327M | $383M | $269M | $295M | $318M | $345M | $150M | $167M | $146M | $173M | $192M | |
| PP&E (Net) | $10M | $9M | $9M | $9M | $9M | $8M | $8M | $8M | $7M | $7M | $5M | $4M | $3M | $3M | $1M | $1M | |
| PP&E (Gross) | · | · | $15M | · | · | · | $12M | · | · | · | $8M | · | · | · | $3M | · | |
| Accum. Depreciation | · | · | $6M | · | · | · | $4M | · | · | · | $3M | · | · | · | $2M | · | |
| Intangibles | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $21M | |
| Other Non-current Assets | $9M | $9M | $6M | $6M | $6M | $6M | $6M | $2M | · | · | $0 | · | · | · | · | · | |
| Total Assets | $228M | $288M | $364M | $252M | $301M | $363M | $418M | $301M | $324M | $329M | $355M | $160M | $176M | $155M | $180M | $220M | |
| Accounts Payable | $17M | $19M | $10M | $10M | $20M | $16M | $12M | $7M | $14M | $7M | $7M | $10M | $11M | $9M | $6M | $6M | |
| Accrued Liabilities | $22M | $16M | $24M | $18M | $11M | $18M | $18M | $14M | $13M | $16M | $18M | $13M | $15M | $10M | $16M | $16M | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $5M | $10M | $10M | |
| Current Liabilities | $42M | $37M | $37M | $30M | $33M | $42M | $49M | $49M | $62M | $63M | $63M | $64M | $69M | $27M | $35M | $34M | |
| Capital Leases | $20M | $20M | $21M | $21M | $22M | $22M | $22M | $22M | $22M | $5M | $5M | $5M | $5M | $6M | $6M | $6M | |
| Other Non-current Liabilities | $23.0K | $55.0K | $87.0K | $118.0K | $148.0K | $177.0K | $205.0K | $233.0K | · | · | $0 | $0 | $0 | $600.0K | $600.0K | $600.0K | |
| Total Liabilities | $62M | $58M | $58M | $52M | $55M | $64M | $82M | $82M | $96M | $79M | $89M | $101M | $118M | $76M | $84M | $84M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | $30M | · | $30M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $35M | · | $40M | |
| Common Stock | $85.0K | $83.0K | $83.0K | $70.0K | $69.0K | $69.0K | $68.0K | $53.0K | $52.0K | $50.0K | $49.0K | $35.0K | $34.0K | $34.0K | $34.0K | $34.0K | |
| Retained Earnings | $-1.28B | $-1.19B | $-1.10B | $-1.04B | $-978M | $-918M | $-873M | $-832M | $-802M | $-771M | $-742M | $-728M | $-715M | $-693M | $-671M | $-628M | |
| AOCI | $793.0K | $802.0K | $961.0K | $919.0K | $832.0K | $923.0K | $1M | $1M | $792.0K | $836.0K | $864.0K | $841.0K | $842.0K | $843.0K | $786.0K | $653.0K | |
| Stockholders' Equity | $166M | $230M | $306M | $200M | $246M | $298M | $337M | $219M | $228M | $250M | $266M | $59M | $57M | $78M | $96M | $136M | |
| Liabilities + Equity | $228M | $288M | $364M | $252M | $301M | $363M | $418M | $301M | $324M | $329M | $355M | $160M | $176M | $155M | $180M | $220M | |
| Shares Outstanding | 84,981,843 | 83,453,001 | 82,826,416 | 69,569,813 | 68,889,649 | 68,811,357 | 68,266,005 | 53,524,364 | 52,160,305 | 49,885,701 | 49,043,074 | 35,309,432 | 34,306,118 | 34,301,926 | 34,082,934 | 34,072,155 |
Arus Kas 14
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $690.0K | $636.0K | $698.0K | $576.0K | $538.0K | $497.0K | $467.0K | $408.0K | $362.0K | $303.0K | $112.0K | · | · | · | · | · | |
| Stock-based Comp | $10M | $12M | $7M | $6M | $7M | $8M | $8M | $7M | $9M | $13M | $4M | $4M | $2M | $3M | $3M | $3M | |
| Deferred Tax | · | · | $369.0K | $0 | · | · | $90.0K | $0 | · | · | · | · | · | · | · | · | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $205.0K | $615.0K | |
| Other Non-cash | · | $-8M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-62M | $-81M | $-65M | $-59M | $-63M | $-53M | $-36M | $-39M | $-20M | $-31M | $-23M | $-15M | $57M | $-17M | $-13M | $-13M | |
| CapEx | $1M | $997.0K | $986.0K | $798.0K | $1M | $276.0K | $384.0K | $2M | $900.0K | $1M | $883.0K | $2M | $396.0K | $484.0K | $585.0K | $1M | |
| Investing Cash Flow | $75M | $59M | $-75M | $55M | $48M | $40M | $-96M | $16M | $-160M | $21M | $-47M | $-2M | $13M | $32M | $33M | $6M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Stock Issued | · | · | $167M | $7M | · | · | $152M | · | · | · | $216M | · | · | · | $0 | · | |
| Financing Cash Flow | $20M | $-3M | $167M | $7M | $238.0K | $-951.0K | $152M | $12M | $329.0K | $115.0K | $218M | $10M | $-37M | $-5M | $-58.0K | $92.0K | |
| Net Change in Cash | $33M | $-24M | $27M | $3M | $-14M | $-15M | $20M | $-11M | $-180M | $-10M | $148M | $-7M | $34M | $10M | $20M | $-7M | |
| Free Cash Flow | · | $-82M | · | · | · | $-53M | · | · | · | $-32M | · | · | · | $-17M | · | · |
Profitabilitas 7
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -19207.1% | -12532.5% | · | -6420.8% | -1166.8% | -199.7% | · | -311.2% | -364.5% | -285.2% | · | -94.7% | -250.0% | -280.5% | · | -183.8% | |
| Net Margin | -18633.1% | -12188.5% | · | -6183.4% | -1114.3% | -184.8% | · | -279.0% | -325.3% | -250.6% | · | -83.0% | -251.7% | -275.5% | · | -184.0% | |
| Pretax Margin | -18633.1% | · | · | -6183.4% | -1112.6% | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -19207.1% | -12441.1% | · | -6420.8% | -1166.8% | -199.7% | · | -311.2% | -364.5% | -285.2% | · | -94.7% | -250.0% | -280.5% | · | -183.8% | |
| ROA | -35.7% | -26.1% | · | -21.6% | -19.0% | -13.1% | · | -12.7% | -12.3% | -12.1% | · | -6.6% | -11.2% | -10.6% | · | -9.5% | |
| ROE | -45.8% | -32.1% | · | -28.5% | -25.1% | -16.5% | · | -21.2% | -21.6% | -17.8% | · | -12.9% | -22.0% | -17.3% | · | -16.1% | |
| ROIC | -58.5% | · | · | -31.0% | -25.3% | · | · | · | · | · | · | · | · | · | · | · |
Likuiditas & Solvabilitas 5
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.5 | 6.7 | · | 7.2 | 8.0 | 7.8 | · | 5.5 | 4.7 | 5.1 | · | 2.4 | 2.4 | 5.4 | · | 5.6 | |
| Quick Ratio | 4.3 | 5.9 | · | 6.8 | 7.7 | 7.6 | · | 5.2 | 4.5 | 4.8 | · | 2.1 | 2.1 | 4.5 | · | 4.6 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.4 | · | 0.3 | |
| LT Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.4 | · | 0.2 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | · | -52.3 | -26.5 | · | -27.8 |
Efisiensi 2
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.1 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.0 | 0.0 | · | 0.1 | |
| Inventory Turnover | · | · | · | · | · | · | · | 0.2 | 0.4 | 0.2 | · | · | · | · | · | · |
Valuasi (TTM) 14
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $8M | $31M | · | $41M | $50M | $56M | · | $47M | $45M | $44M | · | $42M | $38M | $39M | · | $40M | |
| Net Income TTM | $-298M | $-249M | · | $-194M | $-165M | $-135M | · | $-102M | $-96M | $-86M | · | $-75M | $-82M | $-80M | · | $-75M | |
| Market Cap | $1.22B | $1.08B | · | $991M | $648M | $373M | · | $428M | $454M | $1.03B | · | $282M | $298M | $101M | · | $270M | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | $146M | $156M | $13M | · | $152M | |
| P/E | -3.8 | -3.9 | · | -4.9 | -3.6 | -2.3 | · | -4.0 | -4.2 | -10.1 | · | -4.0 | -4.0 | -1.4 | · | -3.7 | |
| P/S | 162.0 | 34.2 | · | 24.0 | 13.0 | 6.6 | · | 9.1 | 10.0 | 23.6 | · | 6.7 | 7.8 | 2.6 | · | 6.7 | |
| P/B | 7.3 | 4.7 | · | 4.9 | 2.6 | 1.2 | · | 2.0 | 2.0 | 4.1 | · | 4.8 | 5.2 | 1.3 | · | 2.0 | |
| P / Tangible Book | 7.3 | 4.7 | · | 4.9 | 2.6 | 1.2 | · | 2.0 | 2.0 | 4.1 | · | 4.8 | 5.2 | 1.3 | · | 2.3 | |
| P / Cash Flow | · | -13.4 | · | · | · | -7.0 | · | · | · | -33.1 | · | · | · | -6.0 | · | · | |
| P / FCF | · | -13.2 | · | · | · | -7.0 | · | · | · | -31.9 | · | · | · | -5.8 | · | · | |
| EV / EBITDA | · | · | · | · | · | · | · | · | · | · | · | -10.1 | -6.9 | -0.6 | · | -8.3 | |
| EV / FCF | · | · | · | · | · | · | · | · | · | · | · | · | · | -0.8 | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | · | · | 3.5 | 4.1 | 0.3 | · | 3.8 | |
| Earnings Yield | -26.4% | -25.9% | · | -20.3% | -27.8% | -42.8% | · | -25.0% | -23.8% | -9.9% | · | -24.9% | -25.1% | -72.5% | · | -27.2% |
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
Laporan Laba Rugi
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Pendapatan | $31M | $43M | $46M | $41M | $37M |
| Margin Operasi % | -776.0% | -337.1% | -163.1% | -240.6% | -149.6% |
| Laba Bersih | $-232M | $-131M | $-71M | $-102M | $-58M |
| EPS Dilusian | $-3.17 | $-2.32 | $-1.82 | $-2.74 | $-2.03 |
Neraca
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Utang / Ekuitas | — | — | 0.0 | 0.4 | 0.2 |
| Rasio Lancar | 8.9 | 7.8 | 5.5 | 5.0 | 10.0 |
| Rasio Cepat | 8.3 | 7.6 | 5.2 | 4.2 | 8.9 |
Arus Kas
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Arus Kas Bebas | $-243M | $-130M | $-2M | $-67M | $-50M |
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik ➕ di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Pemilik institusional (13F) 217 pengaju · $1.2B total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 37 (-18 vs Kuartal sebelumnya) | 20 (-3 vs Kuartal sebelumnya) | 63 (-9 vs Kuartal sebelumnya) | 56 (+18 vs Kuartal sebelumnya) | +8.5M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| MONTANOVA CAPITAL, LLC | $118.638.163 | 8.296.375 | 10,19% | Saham |
| Cormorant Asset Management, LP | $100.100.000 | 7.000.000 | 8,60% | Saham |
| VANGUARD GROUP INC | $78.353.343 | 4.288.634 | 6,73% | Saham |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $69.037.426 | 4.827.792 | 5,93% | Saham |
| Commodore Capital LP | $65.780.000 | 4.600.000 | 5,65% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $51.912.604 | 3.630.252 | 4,46% | Saham |
| JANUS HENDERSON GROUP PLC | $45.962.750 | 3.565.768 | 3,95% | Saham |
| Paradigm Biocapital Advisors LP | $41.332.677 | 2.890.397 | 3,55% | Saham |
| STATE STREET CORP | $33.712.894 | 2.357.545 | 2,90% | Saham |
| Aberdeen Group plc | $28.725.869 | 2.008.802 | 2,47% | Saham |
| PERCEPTIVE ADVISORS LLC | $28.600.000 | 2.000.000 | 2,46% | Opsi jual |
| Balyasny Asset Management L.P. | $25.916.719 | 1.812.358 | 2,23% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $25.269.659 | 1.766.745 | 2,17% | Saham |
| CITADEL ADVISORS LLC | $25.214.389 | 1.763.244 | 2,17% | Saham |
| Parkman Healthcare Partners LLC | $18.420.731 | 1.288.163 | 1,58% | Saham |
| EVENTIDE ASSET MANAGEMENT, LLC | $17.811.837 | 1.245.583 | 1,53% | Saham |
| TWO SIGMA INVESTMENTS, LP | $16.890.345 | 1.181.143 | 1,45% | Saham |
| Essex Woodlands Management, Inc. | $15.513.455 | 1.084.857 | 1,33% | Saham |
| ORBIMED ADVISORS LLC | $15.288.802 | 1.069.147 | 1,31% | Saham |
| 5AM Venture Management, LLC | $15.015.000 | 1.050.000 | 1,29% | Saham |
| Rosalind Advisors, Inc. | $14.131.689 | 988.230 | 1,21% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $13.885.500 | 971.014 | 1,19% | Saham |
| HSBC HOLDINGS PLC | $11.918.407 | 833.455 | 1,02% | Saham |
| Candriam S.C.A. | $11.254.258 | 787.769 | 0,97% | Saham |
| AMERIPRISE FINANCIAL INC | $11.087.640 | 775.357 | 0,95% | Saham |
| DIMENSIONAL FUND ADVISORS LP | $11.062.981 | 773.635 | 0,95% | Saham |
| Artia Global Partners LP | $10.969.501 | 767.098 | 0,94% | Saham |
| Blue Owl Capital Holdings LP | $10.905.094 | 762.594 | 0,94% | Saham |
| Patient Square Capital LP | $10.296.000 | 720.000 | 0,88% | Saham |
| Principia Wealth Advisory, LLC | $9.696.346 | 530.725 | 0,83% | Saham |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $9.260.866 | 647.613 | 0,80% | Saham |
| Sio Capital Management, LLC | $8.910.759 | 623.130 | 0,77% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $7.996.789 | 559.216 | 0,69% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $7.899.320 | 552.400 | 0,68% | Opsi beli |
| Alyeska Investment Group, L.P. | $7.284.463 | 509.403 | 0,63% | Saham |
| MILLENNIUM MANAGEMENT LLC | $7.151.330 | 500.093 | 0,61% | Saham |
| Simplify Asset Management Inc. | $5.720.629 | 400.044 | 0,49% | Saham |
| Ikarian Capital, LLC | $5.296.720 | 370.400 | 0,46% | Opsi beli |
| Ikarian Capital, LLC | $5.296.720 | 370.400 | 0,46% | Opsi jual |
| Ghisallo Capital Management LLC | $5.005.000 | 350.000 | 0,43% | Saham |
| STEMPOINT CAPITAL LP | $4.840.135 | 338.471 | 0,42% | Saham |
| E Fund Management Co., Ltd. | $4.730.068 | 330.774 | 0,41% | Saham |
| Jump Financial, LLC | $4.586.825 | 320.757 | 0,39% | Saham |
| Bleichroeder LP | $4.526.165 | 316.515 | 0,39% | Saham |
| Woodline Partners LP | $4.296.621 | 300.463 | 0,37% | Saham |
| Eversept Partners, LP | $4.257.610 | 297.735 | 0,37% | Saham |
| GOLDMAN SACHS GROUP INC | $4.086.797 | 285.790 | 0,35% | Saham |
| Rock Springs Capital Management LP | $3.839.822 | 268.519 | 0,33% | Saham |
| CITIGROUP INC | $3.750.032 | 262.240 | 0,32% | Saham |
| MYDA Advisors LLC | $3.575.000 | 250.000 | 0,31% | Saham |
| AXA Investment Managers S.A. | $3.480.640 | 244.427 | 0,30% | Saham |
| UBS Group AG | $3.373.442 | 235.905 | 0,29% | Saham |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $3.342.639 | 233.751 | 0,29% | Saham |
| Schonfeld Strategic Advisors LLC | $3.285.853 | 229.780 | 0,28% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3.038.750 | 212.500 | 0,26% | Opsi jual |
| Propel Bio Management, LLC | $2.741.954 | 191.745 | 0,24% | Saham |
| Qube Research & Technologies Ltd | $2.704.159 | 189.102 | 0,23% | Saham |
| Walleye Capital LLC | $2.691.560 | 188.221 | 0,23% | Saham |
| Susquehanna Portfolio Strategies, LLC | $2.685.554 | 187.801 | 0,23% | Saham |
| BlackRock, Inc. | $2.649.890 | 185.307 | 0,23% | Saham |
| CITADEL ADVISORS LLC | $2.559.700 | 179.000 | 0,22% | Opsi jual |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $2.389.303 | 169.334 | 0,21% | Saham |
| HighVista Strategies LLC | $2.226.567 | 155.704 | 0,19% | Saham |
| Granahan Investment Management, LLC | $2.136.234 | 149.387 | 0,18% | Saham |
| Swiss National Bank | $2.034.890 | 142.300 | 0,17% | Saham |
| STATE OF WISCONSIN INVESTMENT BOARD | $1.998.711 | 139.770 | 0,17% | Saham |
| PANAGORA ASSET MANAGEMENT INC | $1.890.660 | 132.214 | 0,16% | Saham |
| Corient Private Wealth LP | $1.827.526 | 127.799 | 0,16% | Saham |
| ESSEX INVESTMENT MANAGEMENT CO LLC | $1.740.081 | 121.684 | 0,15% | Saham |
| BOOTHBAY FUND MANAGEMENT, LLC | $1.548.690 | 108.300 | 0,13% | Opsi beli |
| BOOTHBAY FUND MANAGEMENT, LLC | $1.548.690 | 108.300 | 0,13% | Opsi jual |
| DIADEMA PARTNERS LP | $1.520.090 | 106.300 | 0,13% | Opsi beli |
| SILVERBACK ASSET MANAGEMENT LLC | $1.430.000 | 100.000 | 0,12% | Opsi beli |
| Squarepoint Ops LLC | $1.401.429 | 98.002 | 0,12% | Saham |
| RHUMBLINE ADVISERS | $1.393.341 | 97.437 | 0,12% | Saham |
| CITADEL ADVISORS LLC | $1.357.070 | 94.900 | 0,12% | Opsi beli |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $1.354.752 | 105.101 | 0,12% | Saham |
| ALGERT GLOBAL LLC | $1.129.557 | 78.990 | 0,10% | Saham |
| Waverly Advisors, LLC | $1.114.170 | 77.914 | 0,10% | Saham |
| Cinctive Capital Management LP | $1.037.923 | 72.582 | 0,09% | Saham |
| Caption Management, LLC | $1.036.750 | 72.500 | 0,09% | Opsi beli |
| WELLINGTON MANAGEMENT GROUP LLP | $1.035.134 | 72.387 | 0,09% | Saham |
| GOLDMAN SACHS GROUP INC | $1.002.430 | 70.100 | 0,09% | Opsi beli |
| DEUTSCHE BANK AG\ | $989.860 | 69.221 | 0,09% | Saham |
| Bank of New York Mellon Corp | $981.824 | 68.659 | 0,08% | Saham |
| WOODSTOCK CORP | $979.049 | 68.465 | 0,08% | Saham |
| ALLIANCEBERNSTEIN L.P. | $971.081 | 75.336 | 0,08% | Saham |
| BANK OF AMERICA CORP /DE/ | $930.186 | 65.048 | 0,08% | Saham |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $865.708 | 60.539 | 0,07% | Saham |
| FOX RUN MANAGEMENT, L.L.C. | $836.950 | 58.528 | 0,07% | Saham |
| Y-Intercept (Hong Kong) Ltd | $732.017 | 51.190 | 0,06% | Saham |
| SILVERBACK ASSET MANAGEMENT LLC | $715.000 | 50.000 | 0,06% | Saham |
| JANE STREET GROUP, LLC | $715.000 | 50.000 | 0,06% | Opsi beli |
| Erste Asset Management GmbH | $705.500 | 50.000 | 0,06% | Saham |
| VANGUARD ASSET MANAGEMENT, Ltd | $702.545 | 49.129 | 0,06% | Saham |
| Point72 Asset Management, L.P. | $694.608 | 48.574 | 0,06% | Saham |
| SBI Okasan Asset Management Co.Ltd. | $644.827 | 45.700 | 0,06% | Saham |
| MetLife Investment Management, LLC | $621.607 | 43.469 | 0,05% | Saham |
| JANE STREET GROUP, LLC | $597.954 | 41.815 | 0,05% | Saham |
| SCOTIA CAPITAL INC. | $597.039 | 41.751 | 0,05% | Saham |
Orang dalam perusahaan 25 orang dalam · 12 pejabat · 16 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Jay S. Duker | President and CEO | 10 Juli 2026 M | 9.594 | 0 | 0 | $0 |
| Nancy Lurker | President & CEO | 12 Okt. 2018 A | 211.700 | 0 | 0 | $0 |
| Paul Ashton | President & CEO | 18 Maret 2016 M | 450.741 | 0 | 0 | $0 |
| David Price | Chief Financial Officer | 1 Agu 2018 A | — | 0 | 0 | $0 |
| Michael Soja | VP Finance, CFO & Treasurer | 10 Sep. 2008 A | — | 0 | 0 | $0 |
| Ramiro Ribeiro | Chief Medical Officer | 30 Juni 2026 M | 0 | 0 | 2 | $-73.174 |
| Leonard S Ross | Vice President of Finance and Chief Accounting Officer | 22 Des. 2018 M | 76.187 | 0 | 0 | $0 |
| Dario A. Paggiarino | Chief Medical Officer | 12 Okt. 2018 F | 29.600 | 0 | 0 | $0 |
| Leonard M Blum | Executive VP and General Manager, US | 14 Mei 2018 A | — | 0 | 0 | $0 |
| Debora Jorn | EVP, Corp. & Comm'l Dev. | 27 Juni 2017 A | — | 0 | 0 | $0 |
| Lori Freedman | VP Corporate Affairs, General Counsel and Secretary | 21 Juli 2016 A | 96.423 | 0 | 0 | $0 |
| Aaron Finlay | Secretary | 18 Okt. 2007 A | — | 0 | 0 | $0 |
| Karen L. Zaderej | Direktur | 18 Agu 2026 P | 49.100 | 1 | 0 | $52.258 |
| Wendy F Dicicco | Direktur | 2 Jan. 2026 A | — | 0 | 0 | $0 |
| ANDO GORAN | Direktur | 2 Jan. 2026 A | — | 0 | 0 | $0 |
| Fred Hassan | Direktur | 2 Jan. 2026 A | — | 0 | 0 | $0 |
| Michael W Rogers | Direktur | 15 Nov. 2018 M | 112.500 | 0 | 0 | $0 |
| John B. Landis | Direktur | 25 Okt. 2018 A | — | 0 | 0 | $0 |
| David J Mazzo | Direktur | 6 Sep. 2018 A | 138.000 | 0 | 0 | $0 |
| Douglas Evan Godshall | Direktur | 27 Juni 2018 M | 12.500 | 0 | 0 | $0 |
| James J Barry | Direktur | 7 Mei 2018 M | 12.500 | 0 | 0 | $0 |
| Kristine Peterson | Direktur | 15 Des. 2017 A | — | 0 | 0 | $0 |
| SAVAS PETER G | Direktur | 3 Des. 2015 A | — | 0 | 0 | $0 |
| Paul Hopper | Direktur | 18 Des. 2013 A | 10.000 | 0 | 0 | $0 |
| Katherine Woodthorpe | Direktur | 27 Nov. 2007 A | — | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Aktivis & pemilik 5%+ 5 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| EW Healthcare Partners L.P., EW Healthcare Partners-A L.P., Essex Woodlands Fund IX-GP, L.P., Essex Woodlands IX, LLC, Martin P. Sutter, R. Scott Barry, Ronald Eastman, Petri Vainio, Steve Wiggins ×4 pengajuan | 8 Des. 2023 | — | Pengajuan awal | — | SEC |
| Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan | 30 Agu 2023 | — | Pengajuan awal | — | SEC |
| Ocumension Therapeutics | 22 Jan. 2021 | — | Pengajuan awal | — | SEC |
| IRS Identification Nos. of above persons (entities only) Pfizer Inc. ×2 pengajuan | 26 Mei 2017 | — | Pengajuan awal | — | SEC |
| Pfizer Inc. | 17 Juli 2007 | — | Pengajuan awal | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Kepemilikan ETF Dimiliki oleh 42 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| PILL · Direxion Shares ETF Trust | 1,18% | 11.564 NS | 30 April 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,61% | 17.260 NS | 30 April 2026 | N-PORT |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,51% | 8.244 SH | 8 Agu 2026 | Harian |
| IWC · iShares Trust | 0,23% | 262.360 SH | 8 Agu 2026 | Harian |
| IHE · iShares Trust | 0,22% | 281.199 SH | 8 Agu 2026 | Harian |
| FSCC · Federated Hermes ETF Trust | 0,12% | 25.180 NS | 31 Mei 2026 | N-PORT |
| NUSC · Nushares ETF Trust | 0,08% | 78.250 NS | 30 April 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,08% | 4.561 SH | 8 Agu 2026 | Harian |
| VFMO · VANGUARD WELLINGTON FUND | 0,06% | 86.797 SH | 8 Agu 2026 | Harian |
| BIB · ProShares Trust | 0,06% | 3.062 NS | 31 Mei 2026 | N-PORT |
| IWO · iShares Trust | 0,05% | 592.383 SH | 8 Agu 2026 | Harian |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,05% | 69.310 SH | 8 Agu 2026 | Harian |
| GSSC · Goldman Sachs ETF Trust | 0,04% | 25.575 NS | 31 Mei 2026 | N-PORT |
| IWM · iShares Trust | 0,03% | 1.980.136 SH | 8 Agu 2026 | Harian |
| RSSL · Global X Funds | 0,03% | 33.518 NS | 30 April 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,03% | 445.218 SH | 8 Agu 2026 | Harian |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,03% | 61.360 SH | 8 Agu 2026 | Harian |
| ISCV · iShares Trust | 0,03% | 15.627 SH | 8 Agu 2026 | Harian |
| ITWO · ProShares Trust | 0,03% | 3.648 NS | 31 Mei 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,02% | 378.469 NS | 31 Mei 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 34.174 NS | 30 April 2026 | N-PORT |
| UWM · ProShares Trust | 0,02% | 2.853 NS | 31 Mei 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,01% | 152.391 NS | 30 April 2026 | N-PORT |
| ISCB · iShares Trust | 0,01% | 3.155 SH | 8 Agu 2026 | Harian |
| URTY · ProShares Trust | 0,01% | 2.885 NS | 31 Mei 2026 | N-PORT |
| IWN · iShares Trust | 0,01% | 120.933 SH | 8 Agu 2026 | Harian |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 901.417 SH | 8 Agu 2026 | Harian |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 11.210 SH | 8 Agu 2026 | Harian |
| VHT · VANGUARD WORLD FUND | 0,01% | 213.549 SH | 8 Agu 2026 | Harian |
| WSML · iShares Trust | 0,01% | 4.526 SH | 8 Agu 2026 | Harian |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 2.895 NS | 31 Mei 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 72 NS | 31 Mei 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,00% | 28.026 NS | 31 Mei 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 3.564 NS | 30 April 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 111.667 SH | 8 Agu 2026 | Harian |
| IWV · iShares Trust | 0,00% | 21.976 SH | 8 Agu 2026 | Harian |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 46.188 NS | 31 Mei 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 10.667 NS | 30 April 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 41.879 NS | 30 April 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 13.282 NS | 30 April 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2.643.860 SH | 8 Agu 2026 | Harian |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 6.035 SH | 8 Agu 2026 | Harian |